# Ensysce Biosciences, Inc. (ENSC): Dividend & Fundamentals

> Markdown mirror of https://www.dividenddata.com/stocks/ensc for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice.

- Sector: Healthcare · Industry: Biotechnology
- Exchange: NASDAQ · Trading currency: USD

Ensysce Biosciences, Inc. is a clinical-stage pharmaceutical firm dedicated to developing novel prescription drugs for the treatment of severe pain in the United States, with a specific focus on preventing opioid addiction, misuse, abuse, and overdose. The company leverages two primary technological frameworks: the Trypsin Activated Abuse Protection (TAAP) platform, which creates opioid prodrugs designed to resist abuse, and the Multi-Pill Abuse Resistance (MPAR) platform, engineered to offer protection against overdose through its advanced opioid prodrug technology. Ensysce's pipeline feat...

## Quote & Key Metrics

As of 2026-10-23:

| Metric | Value |
|---|---|
| Price | $0.47 USD |
| Market Cap | $9.2M |
| P/E (TTM) | — |
| EPS (TTM) | −$2.76 |
| 52-Week Range | $0.23 – $2.26 |
| Dividend Yield (TTM) | — |

## Dividend

ENSC has no dividend payment history in our records.

## Frequently Asked Questions

### What does Ensysce Biosciences, Inc. do?

Ensysce Biosciences, Inc. (ENSC) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

### What is ENSC's market cap?

Ensysce Biosciences, Inc. (ENSC) has a market capitalization of approximately $9.2 million, as of October 23, 2026, based on the most recent share price and shares outstanding.

### Does ENSC pay a dividend?

No, Ensysce Biosciences, Inc. (ENSC) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

### Is ENSC profitable?

Ensysce Biosciences, Inc. (ENSC) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

### Has ENSC ever paid a dividend?

No. Dividend Data's records show no dividend payments from Ensysce Biosciences, Inc. (ENSC). A first dividend would appear on the Dividend tab once it is declared.

## More on Dividend Data

- Overview (HTML): https://www.dividenddata.com/stocks/ensc
- Dividend history & safety: https://www.dividenddata.com/stocks/ensc/dividend
- Earnings & EPS: https://www.dividenddata.com/stocks/ensc/earnings
- Financial statements: https://www.dividenddata.com/stocks/ensc/financials/income
- Valuation multiples: https://www.dividenddata.com/stocks/ensc/valuation
- Peer comparison: https://www.dividenddata.com/stocks/ensc/peers

Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.